Biotech Values

[isolution]

Today's press



In France agrees on the difficulty of Sanofi-Aventis merging due to shareholder disagreement (Total would like but L'oreal don't want, more than 25% of their actal profits) and also to the politics, whether it would create the #2 biggest pharam company (after Pfizer), the jobs cut is considered here unbereable by politicians.